-
1.发明公开OXOAZETIDINE DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND USE THEREOF IN HUMAN MEDICINE AND IN COSMETICS 审中-公开OXOAZETIDINDERIVATE，其制造方法相同，它们在人类药物及化妆品
公开(公告)号：EP2342194A1
公开(公告)日：2011-07-13
申请号：EP09744417.8
申请日：2009-11-04
发明人： BOUIX-PETER, Claire , SUZUKI, Itaru , RODEVILLE, Nicolas , MAUVAIS, Pascale , PASCAL, Jean-Claude
IPC分类号： C07D401/12 , C07D403/12 , A61K31/4178
CPC分类号： C07D403/12 , A61K8/4906 , A61K8/494 , A61K31/4178 , A61K2800/78 , A61Q5/10 , A61Q17/04 , A61Q19/004 , A61Q19/007 , A61Q19/008 , A61Q19/02 , A61Q19/04 , C07D401/12 , Y02A50/463
摘要： Compounds derived from oxoazetidine corresponding to general formula (I) compositions containing same, processes for their preparation and their use in pharmaceutical or cosmetic compositions are described.
-
2.发明公开NOVEL TYROSINASE INHIBITORS, THEIR PROCESS OF PREPARATION AND THEIR USE IN HUMAN MEDICINE AND IN COSMETICS 审中-公开新的酪氨酸酶，工艺用于生产相同的，它们在人类医药和化妆品
公开(公告)号：EP2041095A1
公开(公告)日：2009-04-01
申请号：EP07787294.3
申请日：2007-07-10
IPC分类号： C07D233/84 , A61K31/4164 , A61K8/49 , A61P17/02 , A61Q19/08
CPC分类号： C07D233/84
摘要： The present invention relates to the use of compounds corresponding to the following general formula (I) in pharmaceutical compositions intended for use in human or veterinary medicine or else in cosmetic compositions, and also to novel compounds of formula (II) and to the compositions comprising them.
-
3.发明授权
公开(公告)号：EP2790692B1
公开(公告)日：2016-11-23
申请号：EP12808360.7
申请日：2012-12-17
IPC分类号： A61K31/165 , A61K31/192 , A61K31/216 , A61K38/00 , A61K45/06 , A61P17/00 , A61K31/4178 , A61K31/454
CPC分类号： A61K31/216 , A61K31/165 , A61K31/192 , A61K31/4178 , A61K31/454 , A61K38/33 , A61K38/34 , A61K38/35 , A61K45/06 , A61K2300/00
-
4.发明公开
公开(公告)号：EP2790692A1
公开(公告)日：2014-10-22
申请号：EP12808360.7
申请日：2012-12-17
IPC分类号： A61K31/165 , A61K31/192 , A61K31/216 , A61K38/00 , A61K45/06 , A61P17/00
CPC分类号： A61K31/216 , A61K31/165 , A61K31/192 , A61K31/4178 , A61K31/454 , A61K38/33 , A61K38/34 , A61K38/35 , A61K45/06 , A61K2300/00
摘要： The invention relates to a combination of compounds for the treatment and/or prevention of skin conditions linked to hypopigmentation. It is characterized by a combination product comprising at least one prostaglandin receptor agonist and at least one MC1R receptor agonist, as a medicament for use simultaneously, separately or spread out over time for the treatment and/or prevention of skin conditions linked to hypopigmentation, such as vitiligo.
-
5.发明授权MELANOCORTIN RECEPTOR MODULATORS, PROCESS FOR PREPARING THEM AND USE THEREOF IN HUMAN MEDICINE AND COSMETICS 有权MELANOCORTINREZEPTORMODULATOREN，其制造方法相同，它们在人类药物及化妆品
公开(公告)号：EP2352728B1
公开(公告)日：2014-05-21
申请号：EP09744418.6
申请日：2009-11-04
发明人： BOUIX-PETER, Claire , SUZUKI, Itaru , PELISSON, Isabelle , COLLETTE, Pascal , TABET, Samuel , LAFITTE, Guillaume
IPC分类号： C07D401/12 , C07D403/12
CPC分类号： C07D401/12 , C07D403/12
-
公开(公告)号：EP2342194B1
公开(公告)日：2018-08-08
申请号：EP09744417.8
申请日：2009-11-04
发明人： BOUIX-PETER, Claire , SUZUKI, Itaru , RODEVILLE, Nicolas , MAUVAIS, Pascale , PASCAL, Jean-Claude
IPC分类号： C07D401/12 , C07D403/12 , A61K31/4178
CPC分类号： C07D403/12 , A61K8/4906 , A61K8/494 , A61K31/4178 , A61K2800/78 , A61Q5/10 , A61Q17/04 , A61Q19/004 , A61Q19/007 , A61Q19/008 , A61Q19/02 , A61Q19/04 , C07D401/12 , Y02A50/463
摘要： Compounds derived from oxoazetidine corresponding to general formula (I) compositions containing same, processes for their preparation and their use in pharmaceutical or cosmetic compositions are described.
-
7.发明公开MELANOCORTIN RECEPTOR MODULATORS, PROCESS FOR PREPARING THEM AND USE THEREOF IN HUMAN MEDICINE AND COSMETICS 有权MELANOCORTINREZEPTORMODULATOREN，其制造方法相同，它们在人类药物及化妆品
公开(公告)号：EP2352728A1
公开(公告)日：2011-08-10
申请号：EP09744418.6
申请日：2009-11-04
发明人： BOUIX-PETER, Claire , SUZUKI, Itaru , PELISSON, Isabelle , COLLETTE, Pascal , TABET, Samuel , LAFITTE, Guillaume
IPC分类号： C07D401/12 , C07D403/12
CPC分类号： C07D401/12 , C07D403/12
摘要： The present invention relates to novel melanocortin receptor modulators corresponding to the general formula (I) to compositions containing them, to the process for preparing them and to their use in pharmaceutical or cosmetic compositions.
-
8.发明公开UTILISATION DE 4-PHENYL-IMIDAZOLE-2-THIONES COMME INHIBITEURS DE LA TYROSINASE, POUR LA PRÉPARATION DE COMPOSITIONS PHARMACEUTIQUES OU COSMÉTIQUES DESTINÉES AU TRAITEMENT OU À LA PRÉVENTION DES DÉSORDRES PIGMENTAIRES 审中-公开4-苯基 - 咪唑-2-硫酮ALS酪氨酸酶抑制剂用于药物或化妆品组合物用于治疗或预防色素紊乱的制备中使用
公开(公告)号：EP2164486A2
公开(公告)日：2010-03-24
申请号：EP08805933.2
申请日：2008-06-04
发明人： BOITEAU, Jean-Guy , PELISSON, Isabelle , SUZUKI, Itaru , MUSICKI, Branislav , BERTHIER, Marielle
CPC分类号： A61K31/4164 , A61K8/4946 , A61K2800/782 , A61Q19/02
摘要： The invention relates to the use of 4-phenyl-imidazole-2-thiones as tyrosinase inhibitors for preparing pharmaceutical or cosmetic compositions for treating or preventing pigment disorders. The invention relates to the use of compounds of the following general formula for preparing pharmaceutical or cosmetic compositions for treating or preventing pigment disorders.
-
-
-
-
-
-
-
搜索结果
8 条记录 (耗时 0.015 秒)
